Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2020
Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
Clinical Endocrinology
|
January 15, 2014
No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer
Alexis Vrachimis, Joachim Gerss, Maren Stoyke, et al.
Cancers
|
September 9, 2023
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
Petra Petranović Ovčariček, Alfredo Campenni, Bart de Keizer, et al.
Vitamins and Hormones
|
August 14, 2025
Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Alfredo Campennì, Rosaria Maddalena Ruggeri, et al.
Practical Radiation Oncology
|
June 20, 2025
Combined Hypofractionated Radiation Therapy and Brachytherapy for Managing Prostate-Specific Membrane Antigen Positron Emission Tomography-Staged Organ-Confined Prostate Cancer: Primary Endpoint Analysis of a Prospective Study
Iosif Strouthos, Efstratios Karagiannis, Georgios Antorkas, et al.
Hellenic Journal of Nuclear Medicine
|
April 6, 2025
Head-to-head comparison of <sup>18</sup>F-FDG versus <sup>18</sup>F-FAPI-74 PET in radioactive-iodine refractory differentiated thyroid cancer patients
Panayiotis Hadjitheodorou, Wolfgang Roll, Emmanouil Alevroudis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2016
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer
Alexis Vrachimis, Lars Stegger, Christian Wenning, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia
Julia Krämer, Gero Lueg, Patrick Schiffler, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2024
Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series
Luca Giovanella, Lisa Milan, Wolfgang Roll, et al.
Oncology
|
November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy
Flavio Forrer, Galina Farina Fischer, Ole Maas, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2020
Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
Clinical Endocrinology
|
January 15, 2014
No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer
Alexis Vrachimis, Joachim Gerss, Maren Stoyke, et al.
Cancers
|
September 9, 2023
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
Petra Petranović Ovčariček, Alfredo Campenni, Bart de Keizer, et al.
Vitamins and Hormones
|
August 14, 2025
Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Alfredo Campennì, Rosaria Maddalena Ruggeri, et al.
Practical Radiation Oncology
|
June 20, 2025
Combined Hypofractionated Radiation Therapy and Brachytherapy for Managing Prostate-Specific Membrane Antigen Positron Emission Tomography-Staged Organ-Confined Prostate Cancer: Primary Endpoint Analysis of a Prospective Study
Iosif Strouthos, Efstratios Karagiannis, Georgios Antorkas, et al.
Hellenic Journal of Nuclear Medicine
|
April 6, 2025
Head-to-head comparison of <sup>18</sup>F-FDG versus <sup>18</sup>F-FAPI-74 PET in radioactive-iodine refractory differentiated thyroid cancer patients
Panayiotis Hadjitheodorou, Wolfgang Roll, Emmanouil Alevroudis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2016
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer
Alexis Vrachimis, Lars Stegger, Christian Wenning, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia
Julia Krämer, Gero Lueg, Patrick Schiffler, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2024
Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series
Luca Giovanella, Lisa Milan, Wolfgang Roll, et al.
Oncology
|
November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy
Flavio Forrer, Galina Farina Fischer, Ole Maas, et al.
Page
of 6